Nov 23, 2021 by Brian Orelli, PhD and Keith SpeightsAstraZeneca Decides It's OK to Make Money From the PandemicLackluster third-quarter results may have contributed to the decision to stop selling its COVID-19 vaccine at no profit.
Nov 23, 2021 by Brian Orelli, PhD and Keith SpeightsWill Investors Benefit From Johnson & Johnson's Breakup?It largely depends on what type of investor you are.
Jun 27, 2021 by Brian Orelli, PhD and Keith SpeightsHere's Why Pfizer and BioNTech Are Selling Their Vaccine at CostThe humanitarian move might help the companies gain additional for-profit contracts in the future.
Jun 26, 2021 by Brian Orelli, PhD and Keith SpeightsHere's Why Novavax's Solid Vaccine Data Didn't Move the StockThe results were great news, but widely expected.
Jun 6, 2021 by Brian Orelli, PhD and Keith SpeightsHow Much Will the Nkarta Deal Help CRISPR Therapeutics?Unfortunately, this isn't an endorsement by a big drug developer.
Jun 6, 2021 by Brian Orelli, PhD and Keith SpeightsCan Cathie Wood's Favorite Healthcare Company Make You Rich?Multiple purchases in Wood's ETFs appear to be a strong endorsement of the company.
Jun 6, 2021 by Brian Orelli, PhD and Keith SpeightsHere's What Crushed Exelixis' EarningsR&D spending is hurting earnings, but long-term investors shouldn't be worried.
May 29, 2021 by Brian Orelli, PhD and Keith SpeightsCan a Third Vaccine Shot Help Protect Against Coronavirus Variants?Early results look good for patients and investors.
May 29, 2021 by Brian Orelli, PhD and Keith SpeightsHere's Why 10x Genomics Can't Satisfy Short-Term InvestorsLong-term investors should keep perspective.
May 29, 2021 by Brian Orelli, PhD and Keith SpeightsWill Patent Waivers Hurt COVID-19 Vaccine Companies?Complications should mitigate any issues the companies may face.
May 29, 2021 by Brian Orelli, PhD and Keith SpeightsHow Long Will Fulgent Genetics Benefit From the Pandemic?Genetic testing for the coronavirus is slowing.
May 29, 2021 by Brian Orelli, PhD and Keith SpeightsRegeneron Just Got a COVID-19 BoostIt may be short lived.
May 11, 2021 by Brian Orelli, PhDPfizer and BioNTech's COVID-19 Vaccine Authorized by the FDA for AdolescentsParents are pleased, but the move won't change much for the drug companies from a financial perspective.
May 11, 2021 by Brian Orelli, PhD and Keith SpeightsWill the Blood Clot Issue Hurt AstraZeneca's Vaccine in the Long Term?Investors should be focused on the total picture for the British pharma.
May 11, 2021 by Brian Orelli, PhD and Keith SpeightsHow Will the U.S. Glut of Coronavirus Vaccines Affect Manufacturers?The government is having issues with giving away its excess supply.
May 10, 2021 by Brian Orelli, PhD and Keith SpeightsWhen Will Adolescents Be Eligible for a Coronavirus Vaccine?An FDA authorization could come soon.
May 10, 2021 by Brian Orelli, PhD and Keith SpeightsAre Coronavirus Vaccine Boosters Inevitable?The variants could turn one-time sales into annual revenue.
May 10, 2021 by Brian Orelli, PhD and Keith SpeightsModerna's Vaccine Produces Antibodies for at Least 6 MonthsThe medium-term efficacy is good news.
May 9, 2021 by Brian Orelli, PhD and Keith SpeightsIs Generic-Drug Maker Viatris a Keeper?It depends on what type of investor you are.
May 9, 2021 by Brian Orelli, PhD and Keith SpeightsClearance? Approval? What Should Investors Make of Nano-X's FDA Decision?Here's your guide to the FDA's confusing jargon.
![Here’s_Why_Pfizer_and_BioNTech_Are_Selling_Their_Vaccine_at_Cost[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F631387%2Fheres_why_pfizer_and_biontech_are_selling_their_vaccine_at_cost1.jpg&w=384&op=resize)
![Here’s_Why_Novavax’s_Solid_Vaccine_Data_Didn’t_Move_the_Stock[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F631385%2Fheres_why_novavaxs_solid_vaccine_data_didnt_move_the_stock1.jpg&w=384&op=resize)
![How_Much_Will_the_Nkarta_Deal_Help_CRISPR_Therapeutics[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F629763%2Fhow_much_will_the_nkarta_deal_help_crispr_therapeutics1.jpg&w=384&op=resize)
![Can_Cathie_Wood’s_Favorite_Healthcare_Company_Make_You_Rich[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F629764%2Fcan_cathie_woods_favorite_healthcare_company_make_you_rich1.jpg&w=384&op=resize)
![Here_s_What_Just_Crushed_Exelixis’_Earnings[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F629761%2Fhere_s_what_just_crushed_exelixis_earnings1.jpg&w=384&op=resize)
![Can_a_Third_Vaccine_Shot_Help_Protect_Against_Coronavirus_Variants[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628988%2Fcan_a_third_vaccine_shot_help_protect_against_coronavirus_variants1.jpg&w=384&op=resize)
![Here_s_Why_10x_Genomics_Can’t_Satisfy_Short-Term_Investors[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628994%2Fhere_s_why_10x_genomics_cant_satisfy_short-term_investors1.jpg&w=384&op=resize)
![Will_the_Patent_Waiver_Hurt_COVID-19_Vaccine_Companies[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628986%2Fwill_the_patent_waiver_hurt_covid-19_vaccine_companies1.jpg&w=384&op=resize)
![How_Long_Will_Fulgent_Genetics_Benefit_From_the_Pandemic[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628990%2Fhow_long_will_fulgent_genetics_benefit_from_the_pandemic1.jpg&w=384&op=resize)
![Regeneron_Just_Got_a_COVID-19_Boost[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628991%2Fregeneron_just_got_a_covid-19_boost1.jpg&w=384&op=resize)
![How_Will_the_U.S._Glut_of_Coronavirus_Vaccines_Affect_Manufacturers[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F626211%2Fhow_will_the_us_glut_of_coronavirus_vaccines_affect_manufacturers1.jpg&w=384&op=resize)
![When_Will_Adolescents_Be_Eligible_for_a_Coronavirus_Vaccine[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F626210%2Fwhen_will_adolescents_be_eligible_for_a_coronavirus_vaccine1.jpg&w=384&op=resize)
![Are_Coronavirus_Vaccine_Boosters_Inevitable[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F626179%2Fare_coronavirus_vaccine_boosters_inevitable1.jpg&w=384&op=resize)
![Moderna’s_Vaccine_Produces_Antibodies_for_at_Least_6_Months[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F626178%2Fmodernas_vaccine_produces_antibodies_for_at_least_6_months1.jpg&w=384&op=resize)
![Is_Generic-Drug_Maker_Viatris_a_Keeper[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F626176%2Fis_generic-drug_maker_viatris_a_keeper1.jpg&w=384&op=resize)
![Clearance_Approval_What_Should_Investors_Make_of_Nano-X’s_FDA_Decision[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F626173%2Fclearance_approval_what_should_investors_make_of_nano-xs_fda_decision1.jpg&w=384&op=resize)